Advertisement

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x100px
Employment/Membership › Details

Bico–Joersjö A: management, 202410– General Counsel before Hedin Group + Delphi and Hammarskiöld + PwC

 

Period Period 2024-10-01
Organisations Organisation Bico Group AB (publ)
  Group Bico (Group)
  Organisation 2 PricewaterhouseCoopers (PwC) (Group)
Products Product legal services
  Product 2 laboratory equipment and instruments
Person Person Joersjö, Andréas (Bico 202410– General Counsel before Hedin Group + Delphi and Hammarskiöld + PwC)
     

Bico Group AB. (7/10/24). "Press Release: Andréas Joersjö Appointed as General Counsel for Bico Group AB".

BICO Group AB today announces the appointment of Andréas Joersjö as General Counsel. He will succeed Lotta Bus who has decided to leave BICO to pursue her career outside the Group. Andréas Joersjö will assume his new position by mid-October 2024 at the latest.

Andréas Joersjö has 15+ years of experience working in an international business environment as General Counsel, lawyer, and advisor. Before joining BICO, Andréas has worked for Swedish law firms Delphi and Hammarskiöld & Co, in connection with which he has had several in-house assignments with large companies in various businesses, as well as PwC, and most recently as General Counsel for Hedin Group. For Hedin Group he established and headed the Group’s Legal & Compliance team and was also a member of the Executive Management.

“I would like to thank Lotta Bus for her diligent work during her time with BICO and on behalf of the Board and the Executive Management, I would like to wish her all the best in the future. I am also looking forward to welcoming Andréas Joersjö. He will be a great contribution to our team since he has both experience working as a lawyer and as General Counsel working with M&A and integration of companies in an international setting.”, says Maria Forss, President and CEO, BICO Group AB.

Andréas Joersjö will report to BICO’s President and CEO and be a member of the Executive Management. He will assume his position by mid-October 2024 at the latest.

“I look forward to joining BICO and the new Executive Management – the Group is in an interesting phase with many good opportunities ahead. I want to contribute to BICO’s continued growth journey and support the organization with legal counselling. I will also continue to develop the legal function where I together with my team will safeguard business acumen, governance, and compliance.”, says Andréas Joersjö, assuming General Counsel, BICO Group AB.


For further information, please contact:
Maria Forss, President & CEO, BICO Group AB
Phone: EA Isabella Lundin +46 73 515 99 64
E-mail: [email protected]


The information was submitted for publication, through the agency of the contact person set out above, on July 10, 2024 at 7.00am CEST.


About BICO

BICO is a leading provider of life science solutions and laboratory automation that enable more efficient development of new treatments with more specificity and less need for animal testing.

The company uses bioconvergence as its operating system, combining advanced technologies with biology to streamline and automate workflows within the pharmaceutical and biopharma industries.

With 46,000+ instruments installed in over 65 countries, BICO products and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 12,000 publications.

Operating through three business areas – Bioprinting, Biosciences and Bioautomation – the BICO Group strives towards the long-term ambition of enabling the reduction of the world’s organ shortage and speeding up drug development to create the future of life-saving treatments.

BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com

   
Record changed: 2024-07-15

Advertisement

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x200px

More documents for Bico (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px




» top